Literature DB >> 18751825

How much calcium is in your drinking water? A survey of calcium concentrations in bottled and tap water and their significance for medical treatment and drug administration.

Simon Morr1, Esteban Cuartas, Basil Alwattar, Joseph M Lane.   

Abstract

INTRODUCTION: Different forms of water vary in calcium content. High divalent ion (i.e., Ca(2+), Mg(2+), etc.) concentration is deleterious to the absorption and efficacy of the bisphosphonate group of drugs in osteoporosis treatment. Water with high calcium concentration may also present an alternate pathway of calcium administration. In either case, knowing the actual concentration is critical. HYPOTHESIS: The current paper is a surveillance study. We hypothesize that there is considerable variation in the calcium concentrations in the various water sources: tap water from US and Canadian cities of different regions and purified, spring, and mineral bottled waters. In addition, we hypothesize that the water filter removes a significant amount of minerals including calcium from the water.
METHODOLOGY: Calcium concentrations in various city tap waters, as well as an assorted number of bottled waters, were determined through the direct inspection of scientific data. The effect of filtering was also determined by mineral analysis of mineral water directly before and after filtration. RESULT: The calcium concentration of water varies from 1 to 135 mg/L across the USA and Canada. Most spring waters were found to have a relatively low calcium concentration, with an average of 21.8 mg/L. Purified waters contain a negligible calcium concentration. Mineral waters, on the other hand, were generally found to contain higher calcium concentrations, an average of 208 mg/L of calcium. Filtration was found to remove a considerable amount of calcium from the water, removing 89% on average.
CONCLUSION: Calcium concentration in water varied substantially from different sources in the USA and Canada. Bottled waters presented with concentrations of calcium covering a very large range. Certain tap and bottled waters present with concentrations of calcium sufficient to exhibit a deleterious effect on bisphosphonate treatment. Alternatively, certain waters may be used as a source of calcium that may provide over 40% of the recommended daily intake for calcium.

Entities:  

Year:  2006        PMID: 18751825      PMCID: PMC2488164          DOI: 10.1007/s11420-006-9000-9

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  26 in total

Review 1.  Calcium requirement is a sliding scale.

Authors:  B C Nordin
Journal:  Am J Clin Nutr       Date:  2000-06       Impact factor: 7.045

Review 2.  Pharmacokinetics of alendronate.

Authors:  A G Porras; S D Holland; B J Gertz
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 3.  Osteoporosis prevention, diagnosis, and therapy.

Authors: 
Journal:  NIH Consens Statement       Date:  2000 Mar 27-29

4.  Alendronate for the treatment of osteoporosis in men.

Authors:  E Orwoll; M Ettinger; S Weiss; P Miller; D Kendler; J Graham; S Adami; K Weber; R Lorenc; P Pietschmann; K Vandormael; A Lombardi
Journal:  N Engl J Med       Date:  2000-08-31       Impact factor: 91.245

5.  Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche.

Authors:  Geila S Rozen; Gad Rennert; Roni P Dodiuk-Gad; Hedy S Rennert; Nathan Ish-Shalom; Gissel Diab; Batia Raz; Sofia Ish-Shalom
Journal:  Am J Clin Nutr       Date:  2003-11       Impact factor: 7.045

6.  Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Authors:  U A Liberman; S R Weiss; J Bröll; H W Minne; H Quan; N H Bell; J Rodriguez-Portales; R W Downs; J Dequeker; M Favus
Journal:  N Engl J Med       Date:  1995-11-30       Impact factor: 91.245

7.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

Review 8.  Bisphosphonates: a review of their pharmacokinetic properties.

Authors:  J H Lin
Journal:  Bone       Date:  1996-02       Impact factor: 4.398

9.  Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.

Authors:  J P Devogelaer; H Broll; R Correa-Rotter; D C Cumming; C N De Deuxchaisnes; P Geusens; D Hosking; P Jaeger; J M Kaufman; M Leite; J Leon; U Liberman; C J Menkes; P J Meunier; I Reid; J Rodriguez; A Romanowicz; E Seeman; A Vermeulen; L J Hirsch; A Lombardi; K Plezia; A C Santora; A J Yates; W Yuan
Journal:  Bone       Date:  1996-02       Impact factor: 4.398

10.  Effect of calcium supplementation on bone loss in postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; G D Gamble; S J Sharpe
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

View more
  12 in total

1.  Does It Bind? A Method to Determine the Affinity of Calcium and Magnesium Ions for Polymers Using 1H NMR Spectroscopy.

Authors:  Matthew Wallace; Joshua Holroyd; Agne Kuraite; Haider Hussain
Journal:  Anal Chem       Date:  2022-07-25       Impact factor: 8.008

2.  Zoledronic acid infusion for prevention and treatment of osteoporosis.

Authors:  John A Sunyecz
Journal:  Int J Womens Health       Date:  2010-10-14

Review 3.  Current calcium fortification experiences: a review.

Authors:  Cristina Palacios; G Justus Hofmeyr; Gabriela Cormick; Maria Nieves Garcia-Casal; Juan Pablo Peña-Rosas; Ana Pilar Betrán
Journal:  Ann N Y Acad Sci       Date:  2020-09-18       Impact factor: 5.691

4.  Testing for sensory threshold in drinking water with added calcium: a first step towards developing a calcium fortified water.

Authors:  Gabriela Cormick; Natalia Matamoros; Iris B Romero; Surya M Perez; Cintia White; Dana Z Watson; José M Belizán; Miriam Sosa; M Fernanda Gugole Ottaviano; Eliana Elizagoyen; Lorena Garitta
Journal:  Gates Open Res       Date:  2022-01-10

Review 5.  Optimal Dosing Regimen of Osteoporosis Drugs in Relation to Food Intake as the Key for the Enhancement of the Treatment Effectiveness-A Concise Literature Review.

Authors:  Agnieszka Wiesner; Mariusz Szuta; Agnieszka Galanty; Paweł Paśko
Journal:  Foods       Date:  2021-03-29

Review 6.  Towards the Physics of Calcium Signalling in Plants.

Authors:  Teresa Vaz Martins; Matthew J Evans; Hugh C Woolfenden; Richard J Morris
Journal:  Plants (Basel)       Date:  2013-09-27

Review 7.  Life-course approach to nutrition.

Authors:  P J Mitchell; C Cooper; B Dawson-Hughes; C M Gordon; R Rizzoli
Journal:  Osteoporos Int       Date:  2015-09-28       Impact factor: 4.507

8.  Quantification of Elemental Contaminants in Unregulated Water across Western Navajo Nation.

Authors:  Jonathan Credo; Jaclyn Torkelson; Tommy Rock; Jani C Ingram
Journal:  Int J Environ Res Public Health       Date:  2019-07-31       Impact factor: 3.390

Review 9.  The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.

Authors:  Louise McAlister; Pearl Pugh; Laurence Greenbaum; Dieter Haffner; Lesley Rees; Caroline Anderson; An Desloovere; Christina Nelms; Michiel Oosterveld; Fabio Paglialonga; Nonnie Polderman; Leila Qizalbash; José Renken-Terhaerdt; Jetta Tuokkola; Bradley Warady; Johan Vande Walle; Vanessa Shaw; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2019-10-30       Impact factor: 3.714

10.  Contribution of calcium in drinking water from a South American country to dietary calcium intake.

Authors:  Gabriela Cormick; Mercedes Lombarte; Nicole Minckas; Andrés Porta; Alfredo Rigalli; Jose M Belizán; Natalia Matamoros; Maela Lupo
Journal:  BMC Res Notes       Date:  2020-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.